Sheba Shah, MD
Interventional Pain Medicine · Chandler, AZNPI 1861613267
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Abbott at 46.5% of the total. Reporting peaked in 2023 at $622 and has fallen 79.8% since, to $125 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.
Across 83 payments — averaging $30.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Foundation Fusion Solutions, LLC$282
- SPR Therapeutics, Inc$234
- Boston Scientific$221
- AbbVie$179
- Medtronic$145
- plus $285 from 6 others
What the payments were for
- Food & beverage$2,516100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 57 | $1,170 |
| Foundation Fusion Solutions, LLC | 1 | $282 |
| SPR Therapeutics, Inc | 5 | $234 |
| Boston Scientific | 2 | $221 |
| AbbVie(2 entities) | 10 | $179 |
| Medtronic | 2 | $145 |
| Nevro Corp. | 1 | $143 |
| Stryker | 1 | $70 |
| Fidia Pharma USA Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $19 |
| Shionogi Inc | 1 | $15 |
| Team_makena_llc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$143
- GENERAL PAIN MANAGEMENT$126
- PROCLAIM$125
How this compares
$2,516 in reported general payments places this provider in the 20th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 57 | $868 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $728 |
| Morphine Sulfate ErMorphine Sulfate | 44 | $700 |
| Tizanidine Hcl | 28 | $589 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $506 |
| Gabapentin | 30 | $374 |
| Amitriptyline Hcl | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Chandler
- Lakshman GollapalliChandler$16K
- David RayChandler$14K
- Karl Hurst-WickerChandler$9K
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.